Fundraising FoxThrufloendovascular
Irvine, US · 1 known investors
Find your way into Thrufloendovascular
Sign up to see every warm intro you have to Thrufloendovascular
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Thrufloendovascular team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ThruFlo Endovascular is a clinical-stage medical device company developing a dual-limb bifurcation flow diverter to treat complex intracranial aneurysms at arterial branch points, an indication poorly served by existing side-wall flow diverters. The device deploys as a single modality across the bifurcation to redirect blood flow away from the aneurysm while preserving the daughter vessels, serving interventional neuroradiologists and neurosurgeons.
Founders & leadership
SM
Samuel M. ShaolianCo-founder & CEO
GT
George TeitelbaumCo-founder; Scientific Advisory Board
PQ
Peter QiDirector
Investors · 1
Frequently asked questions
- What does Thrufloendovascular do?
- ThruFlo Endovascular is a clinical-stage medical device company developing a dual-limb bifurcation flow diverter to treat complex intracranial aneurysms at arterial branch points, an indication poorly served by existing side-wall flow diverters. The device deploys as a single modality across the bifurcation to redirect blood flow away from the aneurysm while preserving the daughter vessels, serving interventional neuroradiologists and neurosurgeons.
- Who are Thrufloendovascular's investors?
- Thrufloendovascular's investors include Device of Tomorrow Capital.
- Where is Thrufloendovascular headquartered?
- Thrufloendovascular is headquartered in Irvine, US.